Oncol-话题@MedSci

#Oncol#

2384篇内容 | 2472人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1866356, encodeId=da35186635603, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Front Oncol：初始腹腔镜手术（PLA）与开腹手术(OA) 治疗T1b/T2期胆囊癌(GBC)患者的疗效, objectType=article, longId=220517, objectId=087a22051eeb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=087a22051eeb, replyNumber=0, likeNumber=101, createdTime=2022-05-02, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=087a22051eeb, moduleTitle=Front Oncol：初始腹腔镜手术（PLA）与开腹手术(OA) 治疗T1b/T2期胆囊癌(GBC)患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=087a22051eeb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866380, encodeId=277b186638090, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Hematol Oncol：近30年全球29种癌症的发生率及死亡率, objectType=article, longId=221243, objectId=b59b22124326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b59b22124326, replyNumber=0, likeNumber=65, createdTime=2021-12-01, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b59b22124326, moduleTitle=J Hematol Oncol：近30年全球29种癌症的发生率及死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b59b22124326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866416, encodeId=6c5218664169a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Am J Clin Oncol：Meth-ctDNA或是晚期直肠癌潜在的预后标志物, objectType=article, longId=292035, objectId=07362920358e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07362920358e, replyNumber=0, likeNumber=78, createdTime=2022-06-22, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07362920358e, moduleTitle=Am J Clin Oncol：Meth-ctDNA或是晚期直肠癌潜在的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07362920358e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866300, encodeId=2e5e18663005d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Thorac Oncol：纳武单抗+伊匹单抗治疗晚期非小细胞肺癌的长期疗效, objectType=article, longId=218857, objectId=7f8121885e24, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f8121885e24, replyNumber=0, likeNumber=75, createdTime=2021-10-28, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f8121885e24, moduleTitle=J Thorac Oncol：纳武单抗+伊匹单抗治疗晚期非小细胞肺癌的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f8121885e24)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866578, encodeId=7f5018665e8c2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：采用派姆单抗±化疗治疗复发性/转移性头颈部鳞癌, objectType=article, longId=302189, objectId=e07a302189c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e07a302189c4, replyNumber=0, likeNumber=71, createdTime=2022-08-29, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e07a302189c4, moduleTitle=J Clin Oncol：采用派姆单抗±化疗治疗复发性/转移性头颈部鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e07a302189c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866702, encodeId=93921866e02b9, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Lancet Oncol：艾瑞恩 vs 比卡鲁胺联合ADT治疗转移性激素阳性前列腺癌, objectType=article, longId=738668, objectId=be84e3866836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be84e3866836, replyNumber=0, likeNumber=97, createdTime=2023-01-11, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be84e3866836, moduleTitle=Lancet Oncol：艾瑞恩 vs 比卡鲁胺联合ADT治疗转移性激素阳性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be84e3866836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866555, encodeId=97aa1866555d7, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Thorac Oncol：新冠肺炎诊断的胸部恶性肿瘤患者的明确预测系统, objectType=article, longId=300746, objectId=86ee300e461a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86ee300e461a, replyNumber=0, likeNumber=84, createdTime=2022-05-31, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86ee300e461a, moduleTitle=J Thorac Oncol：新冠肺炎诊断的胸部恶性肿瘤患者的明确预测系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86ee300e461a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866374, encodeId=709b18663e49a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：依鲁替尼联合利妥昔单抗一线治疗套细胞淋巴瘤老年患者的疗效, objectType=article, longId=221135, objectId=393f22113570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=393f22113570, replyNumber=0, likeNumber=96, createdTime=2021-12-08, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=393f22113570, moduleTitle=J Clin Oncol：依鲁替尼联合利妥昔单抗一线治疗套细胞淋巴瘤老年患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=393f22113570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866546, encodeId=741c186654674, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：MSS和MGMT缺失转移性结直肠癌（mCRC）使用替莫唑胺以及联合低剂量伊匹木单抗和那武利尤单抗治疗的疗效, objectType=article, longId=300870, objectId=d1753008e0b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1753008e0b3, replyNumber=0, likeNumber=78, createdTime=2022-05-30, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1753008e0b3, moduleTitle=J Clin Oncol：MSS和MGMT缺失转移性结直肠癌（mCRC）使用替莫唑胺以及联合低剂量伊匹木单抗和那武利尤单抗治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1753008e0b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866324, encodeId=db80186632440, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Front Oncol：神经侵犯是淋巴结阴性结肠癌的预后指标而不是辅助化疗的预测指标, objectType=article, longId=219539, objectId=0b4e219539a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b4e219539a6, replyNumber=0, likeNumber=62, createdTime=2022-07-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b4e219539a6, moduleTitle=Front Oncol：神经侵犯是淋巴结阴性结肠癌的预后指标而不是辅助化疗的预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b4e219539a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866381, encodeId=61101866381c3, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效, objectType=article, longId=221246, objectId=2b0d221246c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0d221246c4, replyNumber=0, likeNumber=79, createdTime=2022-03-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0d221246c4, moduleTitle=Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0d221246c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866639, encodeId=a3a11866639c2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：mFOLFOXIRI+帕尼单抗对比FOLFOX+帕尼单抗一线治疗RAS和BRAF野生型转移性结直肠癌(mCRC)的疗效, objectType=article, longId=729659, objectId=add1e2965928, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=add1e2965928, replyNumber=0, likeNumber=92, createdTime=2023-02-08, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=add1e2965928, moduleTitle=J Clin Oncol：mFOLFOXIRI+帕尼单抗对比FOLFOX+帕尼单抗一线治疗RAS和BRAF野生型转移性结直肠癌(mCRC)的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=add1e2965928)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866342, encodeId=3232186634211, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：早发型结直肠癌患者的治疗依从性优于晚发型，但预后更差！, objectType=article, longId=220117, objectId=4fff22011e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fff22011e0b, replyNumber=0, likeNumber=0, createdTime=2022-07-01, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fff22011e0b, moduleTitle=J Clin Oncol：早发型结直肠癌患者的治疗依从性优于晚发型，但预后更差！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fff22011e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866684, encodeId=dca4186668419, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Lancet Oncol：杜瓦鲁单抗联合曲美木单抗治疗晚期转移性肉瘤, objectType=article, longId=735665, objectId=e7a9e356655a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7a9e356655a, replyNumber=0, likeNumber=80, createdTime=2023-05-20, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7a9e356655a, moduleTitle=Lancet Oncol：杜瓦鲁单抗联合曲美木单抗治疗晚期转移性肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7a9e356655a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866554, encodeId=3d99186655486, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：卡博替尼联合纳武单抗可有效治疗大部分非透明细胞肾癌, objectType=article, longId=301139, objectId=bf52301139d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf52301139d4, replyNumber=0, likeNumber=86, createdTime=2022-05-03, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf52301139d4, moduleTitle=J Clin Oncol：卡博替尼联合纳武单抗可有效治疗大部分非透明细胞肾癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf52301139d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866273, encodeId=039718662e387, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Front Oncol：呋喹替尼+PD-1抑制剂 vs 瑞戈非尼+ PD-1抑制剂治疗难治性微卫星稳定的转移性结直肠癌患者的疗效, objectType=article, longId=218182, objectId=cf9921818260, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf9921818260, replyNumber=0, likeNumber=102, createdTime=2022-08-29, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf9921818260, moduleTitle=Front Oncol：呋喹替尼+PD-1抑制剂 vs 瑞戈非尼+ PD-1抑制剂治疗难治性微卫星稳定的转移性结直肠癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf9921818260)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866633, encodeId=9cfa1866633c6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：EGFR抗体偶联药物MRG003治疗实体肿瘤的安全性和活性, objectType=article, longId=728959, objectId=be9fe2895933, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be9fe2895933, replyNumber=0, likeNumber=80, createdTime=2022-07-28, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be9fe2895933, moduleTitle=JAMA Oncol：EGFR抗体偶联药物MRG003治疗实体肿瘤的安全性和活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be9fe2895933)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866321, encodeId=ecca18663219e, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Front Oncol：新辅助化疗(NAC)后射频消融(RFA)改善可消融的结直肠癌肝转移（CRLM）患者的预后, objectType=article, longId=219341, objectId=c7332193416b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7332193416b, replyNumber=0, likeNumber=55, createdTime=2022-06-14, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7332193416b, moduleTitle=Front Oncol：新辅助化疗(NAC)后射频消融(RFA)改善可消融的结直肠癌肝转移（CRLM）患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7332193416b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866537, encodeId=53cf186653eb5, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：JCOG1008研究表明高复发风险局部晚期头颈癌术后顺铂每周+放疗不劣效于顺铂三周方案, objectType=article, longId=300283, objectId=9daa30028368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9daa30028368, replyNumber=0, likeNumber=92, createdTime=2022-07-08, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9daa30028368, moduleTitle=J Clin Oncol：JCOG1008研究表明高复发风险局部晚期头颈癌术后顺铂每周+放疗不劣效于顺铂三周方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9daa30028368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866417, encodeId=9435186641ea2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：根据UGT1A1基因型定量伊立替康可显著改善晚期直肠癌患者预后, objectType=article, longId=292040, objectId=878529204061, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=878529204061, replyNumber=0, likeNumber=86, createdTime=2022-05-19, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=878529204061, moduleTitle=J Clin Oncol：根据UGT1A1基因型定量伊立替康可显著改善晚期直肠癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=878529204061)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Oncol

2020-05-29

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Front Oncol：初始腹腔镜手术（PLA）与开腹手术(OA) 治疗T1b/T2期胆囊癌(GBC)患者的疗效

2022-05-02

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Hematol Oncol：近30年全球29种癌症的发生率及死亡率

2021-12-01

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Am J Clin Oncol：Meth-ctDNA或是晚期直肠癌潜在的预后标志物

2022-06-22

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Thorac Oncol：纳武单抗+伊匹单抗治疗晚期非小细胞肺癌的长期疗效

2021-10-28

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：采用派姆单抗±化疗治疗复发性/转移性头颈部鳞癌

2022-08-29

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Lancet Oncol：艾瑞恩 vs 比卡鲁胺联合ADT治疗转移性激素阳性前列腺癌

2023-01-11

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Thorac Oncol：新冠肺炎诊断的胸部恶性肿瘤患者的明确预测系统

2022-05-31

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：依鲁替尼联合利妥昔单抗一线治疗套细胞淋巴瘤老年患者的疗效

2021-12-08

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：MSS和MGMT缺失转移性结直肠癌（mCRC）使用替莫唑胺以及联合低剂量伊匹木单抗和那武利尤单抗治疗的疗效

2022-05-30

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Front Oncol：神经侵犯是淋巴结阴性结肠癌的预后指标而不是辅助化疗的预测指标

2022-07-09

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效

2022-03-09

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：mFOLFOXIRI+帕尼单抗对比FOLFOX+帕尼单抗一线治疗RAS和BRAF野生型转移性结直肠癌(mCRC)的疗效

2023-02-08

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：早发型结直肠癌患者的治疗依从性优于晚发型，但预后更差！

2022-07-01

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Lancet Oncol：杜瓦鲁单抗联合曲美木单抗治疗晚期转移性肉瘤

2023-05-20

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：卡博替尼联合纳武单抗可有效治疗大部分非透明细胞肾癌

2022-05-03

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Front Oncol：呋喹替尼+PD-1抑制剂 vs 瑞戈非尼+ PD-1抑制剂治疗难治性微卫星稳定的转移性结直肠癌患者的疗效

2022-08-29

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：EGFR抗体偶联药物MRG003治疗实体肿瘤的安全性和活性

2022-07-28

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Front Oncol：新辅助化疗(NAC)后射频消融(RFA)改善可消融的结直肠癌肝转移（CRLM）患者的预后

2022-06-14

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：JCOG1008研究表明高复发风险局部晚期头颈癌术后顺铂每周+放疗不劣效于顺铂三周方案

2022-07-08

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：根据UGT1A1基因型定量伊立替康可显著改善晚期直肠癌患者预后

2022-05-19

科室
- - 订阅+
  - 更多科室
工具
服务